Gemtide 750mcg Injection

Gemtide 750mcg injection contains teriparatide as its active component. Teriparatide is a synthetic form of parathyroid hormone (PTH), which is naturally produced by the parathyroid glands. It is used in the treatment of osteoporosis, a condition characterised by weakened bones that increases the risk of fractures. Fractures resulting from osteoporosis can significantly impact quality of life, causing pain and limiting mobility. Gemtide 750mcg injection works by stimulating the formation of new bone tissue and increasing bone mineral density. This medication has been shown to speed up bone healing in patients with fractures. It promotes the formation of callus, the initial calcified bridge of new bone that develops during the healing process, enabling faster and more effective recovery. Gemtide 750mcg injection should not be used in patients with known hypersensitivity or allergic reaction to teriparatide or any of its components. It is contraindicated in patients with a history of skeletal malignancies, such as osteosarcoma, or those with bone metastases. Use is not advised in patients who have received prior radiation therapy to the skeleton due to the potential risk of osteosarcoma development.

Postmenopausal osteoporosis Glucocorticoid-induced osteoporosis

Gemtide 750mcg injection, exerts a therapeutic effect by stimulating the formation of new bone tissue and increasing bone mineral density. By activating osteoblasts, the cells responsible for bone formation, it enhances bone strength, reduces fracture risk, and promotes bone healing. It offers significant benefits such as increased bone density, fracture risk reduction, improved quality of life, and serves as an alternative for individuals who have not responded well to other osteoporosis treatments.

Gemtide 750mcg injection is typically administered by a healthcare professional. It is usually given as an injection. The healthcare provider will determine the dosage and duration of treatment based on the specific infection and individual factors.

Bonspark Pen cause some side effects like all medications, although not everyone will experience them. Serious: Hypercalcemia Allergic reactions that affect skin and breathing Skin reactions at the injection site include rashes, bruising, swelling, and itching Osteosarcoma (type of bone cancer) Hypercalcemia (increased level of calcium) Orthostatic hypotension (hypertension when stand after sitting or lying position) Common: Arthralgia Nerve Pain Nausea Sickness Headache Dizziness Increased sweating Breathlessness Muscle cramps Increase in blood cholesterol levels Chest pain Burning sensation below the breast bone Anaemia

Prior to initiating Gemtide 750mcg injection, it is crucial to disclose any preexisting medical conditions, particularly those related to bones or metabolism, as well as provide information about any medications or supplements being taken, to your healthcare professional. Extra care should be taken for individuals with a history of skeletal malignancies or bone metastases, as Gemtide 750mcg injection is not recommended in such cases. Regular monitoring of serum calcium levels is essential to identify and manage hypercalcemia. In patients with orthostatic hypotension or pre-existing hyperparathyroidism, Gemtide 750mcg injection should be used cautiously. The duration of treatment with this medication is generally limited, and its use is not advised in pediatric patients. If you are pregnant or breastfeeding, discussing the potential risks and benefits of Gemtide 750mcg injection with your healthcare provider before considering its use is crucial.